Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dustin Wade Wooten, Ph.D.

Concepts

This page shows the publications Dustin Wooten has written about Female.
Connection Strength

0.070
  1. Multi-Modal Signatures of Tau Pathology, Neuronal Fiber Integrity, and Functional Connectivity in Traumatic Brain Injury. J Neurotrauma. 2019 12 01; 36(23):3233-3243.
    View in: PubMed
    Score: 0.013
  2. 5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate. Neuroimage. 2013 Aug 15; 77:125-32.
    View in: PubMed
    Score: 0.009
  3. Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate. J Cereb Blood Flow Metab. 2012 Aug; 32(8):1546-58.
    View in: PubMed
    Score: 0.008
  4. An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate. Nucl Med Biol. 2011 Oct; 38(7):925-32.
    View in: PubMed
    Score: 0.008
  5. Assessment of Striatal Dopamine Transporter Binding in Individuals With Major Depressive Disorder: In Vivo Positron Emission Tomography and Postmortem Evidence. JAMA Psychiatry. 2019 08 01; 76(8):854-861.
    View in: PubMed
    Score: 0.003
  6. Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects. Eur J Nucl Med Mol Imaging. 2019 Sep; 46(10):2099-2111.
    View in: PubMed
    Score: 0.003
  7. Frontostriatal and Dopamine Markers of Individual Differences in Reinforcement Learning: A Multi-modal Investigation. Cereb Cortex. 2018 12 01; 28(12):4281-4290.
    View in: PubMed
    Score: 0.003
  8. Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans. J Comp Neurol. 2016 May 01; 524(7):1457-71.
    View in: PubMed
    Score: 0.003
  9. Imaging PEG-like nanoprobes in tumor, transient ischemia, and inflammatory disease models. Bioconjug Chem. 2015 Jun 17; 26(6):1061-9.
    View in: PubMed
    Score: 0.003
  10. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors. J Nucl Med. 2014 Dec; 55(12):1973-9.
    View in: PubMed
    Score: 0.002
  11. The effects of chronic alcohol self-administration on serotonin-1A receptor binding in nonhuman primates. Drug Alcohol Depend. 2014 Nov 01; 144:119-26.
    View in: PubMed
    Score: 0.002
  12. Amyloid burden and neural function in people at risk for Alzheimer's Disease. Neurobiol Aging. 2014 Mar; 35(3):576-84.
    View in: PubMed
    Score: 0.002
  13. PET imaging of acetylcholinesterase inhibitor-induced effects on a4ß2 nicotinic acetylcholine receptor binding. Synapse. 2013 Dec; 67(12):882-6.
    View in: PubMed
    Score: 0.002
  14. Measuring a4ß2* nicotinic acetylcholine receptor density in vivo with [(18)F]nifene PET in the nonhuman primate. J Cereb Blood Flow Metab. 2013 Nov; 33(11):1806-14.
    View in: PubMed
    Score: 0.002
  15. Serotonin transporter genotype affects serotonin 5-HT1A binding in primates. J Neurosci. 2013 Feb 06; 33(6):2512-6.
    View in: PubMed
    Score: 0.002
  16. PET imaging of a4ß2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate. J Nucl Med. 2012 Sep; 53(9):1471-80.
    View in: PubMed
    Score: 0.002
  17. Specific a4ß2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey. Synapse. 2011 Dec; 65(12):1309-18.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.